companydata.dkcompanydata.dk

DANISH BIOTECH SPV I P/S: Financial statements 2017

CVR: 30274040

Source: annual report 2017, Danish Business Authority

01/01/2017 – 31/12/2017

DANISH BIOTECH SPV I P/S (CVR 30274040) has filed annual accounts for 2017. In 2017, the company reported a gross profit of EUR -64,760 and a net result of EUR -1,665,730 compared with EUR 266,143 the year before. Equity in the 2017 report amounted to EUR -4,562,677.

Gross Profit
EUR -64,760
Profit/Loss
EUR -1,665,730
Equity
EUR -4,562,677
Total Assets
EUR 16,319,966

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017--65K EUR-1.7M EUR-4.6M EUR-
2016--40K EUR266K EUR-2.9M EUR-
2015--66K EUR12.6M EUR4.8M EUR-
2014--20K EUR-9.2M EUR-7.8M EUR-
2013--62K EUR11.7M EUR14.7M EUR-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on DANISH BIOTECH SPV I P/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

DANISH BIOTECH SPV I P/S: The 2016 annual report is outJul 13, 2017

DANISH BIOTECH SPV I P/S has published its annual report for 2016. Gross profit came to DKK -39,671, and the net result was DKK 266,143.

James Nicolle joins the board of DANISH BIOTECH SPV I P/SJun 14, 2017

As of June 14, 2017, James Nicolle has joined the board of directors of DANISH BIOTECH SPV I P/S.

Martin David Mullins leaves the board of DANISH BIOTECH SPV I P/SJun 14, 2017

As of June 14, 2017, Martin David Mullins has left the board of directors of DANISH BIOTECH SPV I P/S.

Kris Allen joins DANISH BIOTECH SPV I P/S as adm. dir.Jun 14, 2017

As of June 14, 2017, Kris Allen is registered as adm. dir. of DANISH BIOTECH SPV I P/S.

Martin David Mullins steps down as director of DANISH BIOTECH SPV I P/SJun 14, 2017

As of June 14, 2017, Martin David Mullins has stepped down as director of DANISH BIOTECH SPV I P/S.

Martin David Mullins joins the board of DANISH BIOTECH SPV I P/SApr 6, 2017

As of April 6, 2017, Martin David Mullins has joined the board of directors of DANISH BIOTECH SPV I P/S.

James Nicolle joins the board of DANISH BIOTECH SPV I P/SApr 6, 2017

As of April 6, 2017, James Nicolle has joined the board of directors of DANISH BIOTECH SPV I P/S.

James Nicolle leaves the board of DANISH BIOTECH SPV I P/SApr 6, 2017

As of April 6, 2017, James Nicolle has left the board of directors of DANISH BIOTECH SPV I P/S.

Martin David Mullins joins DANISH BIOTECH SPV I P/S as directorApr 6, 2017

As of April 6, 2017, Martin David Mullins is registered as director of DANISH BIOTECH SPV I P/S.

James Nicolle joins DANISH BIOTECH SPV I P/S as adm. dir.Apr 6, 2017

As of April 6, 2017, James Nicolle is registered as adm. dir. of DANISH BIOTECH SPV I P/S.

About DANISH BIOTECH SPV I P/S

DANISH BIOTECH SPV I P/S was a Danish company of the type Kommanditaktieselskab/Partnerselskab based in København V, founded in 2007. The company has been dissolved on 26 September 2022. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named DKA I BIOTECH P/S. In 2021, the company reported a gross profit of EUR -25,339 and a net result of EUR 94,239 compared with EUR -32,410 the year before. Equity in the 2021 report amounted to EUR 45,320.

Source: annual report 2021, Danish Business Authority